JGP Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$929K Buy
4,767
+415
+10% +$86K 0.08% 111
2026
Q1
$977K Sell
4,352
-143
-3% -$35.6K 0.1% 104
2025
Q4
$1.08M Buy
4,495
+224
+5% +$57.3K 0.11% 105
2025
Q3
$1.18M Buy
4,271
+102
+2% +$27.9K 0.13% 92
2025
Q2
$1.08M Buy
4,169
+74
+2% +$17.7K 0.13% 91
2025
Q1
$917K Sell
4,095
-45
-1% -$10.5K 0.12% 99
2024
Q4
$947K Buy
4,140
+31
+0.8% +$7.46K 0.12% 97
2024
Q3
$1M Buy
4,109
+182
+5% +$40.7K 0.13% 90
2024
Q2
$752K Buy
3,927
+227
+6% +$46.1K 0.11% 101
2024
Q1
$733K Buy
3,700
+1,308
+55% +$240K 0.11% 102
2023
Q4
$411K Sell
2,392
-708
-23% -$109K 0.06% 126
2023
Q3
$458K Buy
3,100
+69
+2% +$12.5K 0.08% 116
2023
Q2
$662K Sell
3,031
-218
-7% -$48.6K 0.11% 101
2023
Q1
$711K Sell
3,249
-34
-1% -$7.38K 0.12% 95
2022
Q4
$683K Buy
3,283
+108
+3% +$23.7K 0.13% 92
2022
Q3
$706K Sell
3,175
-160
-5% -$36.4K 0.15% 88
2022
Q2
$725K Buy
3,335
+8
+0.2% +$1.7K 0.15% 86
2022
Q1
$830K Sell
3,327
-365
-10% -$88.3K 0.15% 85
2021
Q4
$904K Buy
3,692
+645
+21% +$167K 0.17% 80
2021
Q3
$803K Buy
3,047
+198
+7% +$54.1K 0.17% 80
2021
Q2
$702K Buy
+2,849
New +$599K 0.15% 85

Other funds holding RMD

JGP Wealth Management's RMD Position: Q2 2026 in Review

JGP Wealth Management increased its ResMed (RMD) stake by 9.5% in Q2 2026, buying an estimated $86K and bringing the position to 4,767 shares worth $929K. The position accounts for 0.08% of the portfolio, ranked #111.

JGP Wealth Management first reported a position in RMD in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.18M in Q3 2025. 222 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • JGP Wealth Management held 4,767 shares of ResMed worth $929K as of Q2 2026.
  • JGP Wealth Management bought 415 ResMed shares in Q2 2026, an estimated $86K.
  • ResMed made up 0.08% of JGP Wealth Management's portfolio in Q2 2026, its #111 holding.
  • JGP Wealth Management first reported a position in ResMed in Q2 2021 and has held it in 21 quarters since.
  • JGP Wealth Management's ResMed position peaked at $1.18M in Q3 2025.
  • 222 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.